In reply [5]

Mayo Clinic Proceedings

Volumn 82, Issue 8, 2007, Pages 1016-1017

  Levinson, Gary M ^a   Pennington, Daniel W ^a  

^a Mercy Medical Center North Iowa   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; UROKINASE;

COST EFFECTIVENESS ANALYSIS; DOSE CALCULATION; DRUG HALF LIFE; FIBRINOLYTIC THERAPY; HUMAN; LETTER; PLEURISY; RECOMMENDED DRUG DOSE;

EID: 34547644852     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/82.8.1016-a     Document Type: Letter

References (3)

1. Eisenberg PR, Sherman LA, Tiefenbrunn AJ, Ludbrook PA, Sobel BE, Jaffe AS. Sustained fibrinolysis after administration of tPA despite its short half-life in the circulation. Thromb Haemost. 1987;57:35-40.
2. Wells RG, Havens PL. Intrapleural fibrinolysis for parapneumonic effusion and empyema in children. Radiology. 2003;228:370-378.
3. Chin NK, Lim TK. Controlled trial of intrapleural streptokinase in the treatment of pleural empyema and complicated parapneumonic effusions. Chest. 1997;111:275-279.